Phosphinic acid derivatives

Details for Australian Patent Application No. 2004295060 (hide)

Owner Novartis AG

Inventors Froestl, Wolfgang

Agent Davies Collison Cave

Pub. Number AU-B-2004295060

PCT Pub. Number WO2005/054259

Priority 0327186.3 21.11.03 GB

Filing date 19 November 2004

Wipo publication date 16 June 2005

Acceptance publication date 30 August 2007

International Classifications

A61K 31/66 (2006.01) - Phosphorus compounds

C07F 9/30 (2006.01) Compounds containing elements of the 5th Group of the Periodic System

C07F 9/58 (2006.01) Compounds containing elements of the 5th Group of the Periodic System

Event Publications

1 June 2006 PCT application entered the National Phase

  PCT publication WO2005/054259 Priority application(s): WO2005/054259

30 August 2007 Application Accepted

  Published as AU-B-2004295060

3 January 2008 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004295061-1H-imidazoquinoline derivatives as protein kinase inhibitors

2004295059-6-substituted 2-quinolinones and 2-quinoxalinones as poly(ADP-ribose) polymerase inhibitors